Hôpitaux Universitaires de Genève
Geneva, Canton of Geneva, 1211, Switzerland
Location status: Recruiting
Location contact
Rey-Millet Quentin RMQuentin Dr
CONTACT
Rey-Millet RMQuentin Quentin, Dr
PRINCIPAL_INVESTIGATOR
NCT Number: NCT07506356
Treatment with semaglutide slows down gastric emptying , food remains in the stomach for a longer period of time. This slowing has important implications for anesthesia management. At present, we do not know the optimal duration for discontinuing this medication before surgery and anesthesia to ensure an empty stomach.
This is an observational research project, conducted exclusively at the Geneva University Hospitals (HUG). To answer the research question, participation of 38 individuals will be required. The duration of participation for each person is 7 days.
To recruit the necessary number of participants, approximately 1.5 years will be needed.
This project is being carried out in accordance with Swiss legal requirements and recognized international guidelines. The competent ethics committee has reviewed and approved this project.
The project will last 7 day during which the participants will need to come 3 times at the hospital to make gastric ultrasounds. On these days the participants will be asked to have a breakfast between 7 and 8 am including a minimum of bread and/or cereals and/or proteins. After that the participants will be asked to fast for 6 hours for solide food and 2 hours for liquids. If the participants smokes, they must for 12h before the exam.
At 2Pm an anesthesiologist will welcome the participant to make the exam at the hospital to evaluate the gastric volume after what the participants will be able to get a small collation and go back home.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Geneva, Canton of Geneva, 1211, Switzerland
Location status: Recruiting
Rey-Millet Quentin RMQuentin Dr
CONTACT
Rey-Millet RMQuentin Quentin, Dr
PRINCIPAL_INVESTIGATOR
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 1 week
Our primary objective is to show that after a fasting period of 6 hours, seven days after the last injection of GLP-1, gastric volume of diabetic patients is safe for anaesthesia. Our hypothesis is that seven days after the last injection of GLP-1, and after a 6h fasting period, the mean gastric volume of treated patients will be lower than 1.5 ml/kg, corresponding to the most accepted volume threshold of an at risk (full) stomach
University Hospital, Geneva
Other
Investigation of Gastric Emptying by Gastric Ultrasonography in Diabetic Patients Treated With GLP-1 Receptors Agonists
Acronym: SAGUSE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07675551
Behavior, Behavior, Animal
Brampton, Ontario, Canada
View Trial DetailsNCT07164495
Diabete Type 2, Diabetes Mellitus
Taichung, Taiwan
View Trial DetailsNCT07212075
Anorexia Nervosa, Anxiety Disorder (Panic Disorder or GAD)
Bad Mergentheim, Baden-Wurttemberg, Germany
View Trial DetailsNCT07563699
Diabete Type 2, Diabetes Mellitus
Tel Aviv, Israel
View Trial Details